Litchfield Hills Research Stock Recommendations and Price Targets

This is a list of recent ratings by Litchfield Hills Research.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
4/12/2024
LVO
LiveOne
Reiterated Rating$2.00 $4.00BuyLow
3/14/2024
SHLT
SHL Telemedicine
Reiterated Rating$5.00 $11.00BuyLow
1/30/2024
ECDA
ECD Automotive Design
Reiterated Rating$1.00 $9.00BuyLow
12/22/2023
SOPA
Society Pass
Reiterated Rating$0.00BuyLow
10/13/2023
LQR
LQR House
Reiterated Rating$1.00BuyLow
7/14/2023
LZGI
LZG International
Initiated Coverage$0.00 $5.00BuyLow
5/25/2023
KWE
KWESST Micro Systems
Reiterated Rating$1.00BuyLow
5/9/2023
LSAK
Lesaka Technologies
Reiterated Rating$4.00BuyLow
4/25/2023
UCASU
UC Asset
Reiterated Rating$0.00BuyLow
4/24/2023
UCL
uCloudlink Group
Reiterated Rating$1.00BuyLow
4/3/2023
USAQ
QHSLab
Reiterated Rating$0.00BuyLow
2/6/2023
ESOA
Energy Services of America
Reiterated Rating$7.00BuyLow
12/1/2022
CODX
Co-Diagnostics
Reiterated Rating$1.00BuyLow
11/23/2022
STRR
Star Equity
Reiterated Rating$1.00BuyLow
11/9/2022
GHM
Graham
Reiterated Rating$28.00BuyLow
10/31/2022
LIVE
Live Ventures
Reiterated Rating$26.00BuyN/A
9/27/2022
SGRP
SPAR Group
Reiterated Rating$2.00BuyLow
8/31/2022
AVNW
Aviat Networks
Reiterated Rating$33.00BuyLow
5/6/2022
TAOP
Taoping
Reiterated Rating$1.00BuyLow
2/28/2022
USAQ
QHSLab
Reiterated Rating$0.00BuyLow
1/14/2022
USAQ
QHSLab
Reiterated Rating$0.00BuyLow
11/30/2021
ADIL
Adial Pharmaceuticals
Reiterated Rating$2.00BuyLow
11/22/2021
KULR
KULR Technology Group
Reiterated Rating$0.00BuyMedium
11/17/2021
COMS
COMSovereign
Reiterated Rating$0.00BuyLow
11/17/2021
STRR
Star Equity
Reiterated Rating$1.00BuyHigh
11/16/2021
POAI
Predictive Oncology
Reiterated Rating$1.00BuyMedium
11/15/2021
CODX
Co-Diagnostics
Reiterated Rating$1.00BuyHigh
11/2/2021
BELFB
Bel Fuse
Reiterated Rating$56.00BuyMedium
10/28/2021
GHM
Graham
Reiterated Rating$28.00BuyLow
9/20/2021
RYMDF
Relay Medical
Reiterated Rating$0.00BuyLow
9/16/2021
OTLC
Oncotelic Therapeutics
Reiterated Rating$0.00BuyLow
8/27/2021
AVNW
Aviat Networks
Reiterated Rating$33.00BuyLow
8/26/2021
ADIL
Adial Pharmaceuticals
Boost Price Target$2.00$125.00 ➝ $375.00BuyHigh
6/29/2021
ADIL
Adial Pharmaceuticals
Initiated Coverage$2.00 $125.00BuyLow